How were Ritter Pharmaceuticals' earnings last quarter?

Ritter Pharmaceuticals Inc (NASDAQ:RTTR) issued its quarterly earnings results on Friday, May, 1st. The biotechnology company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.01.

When did Ritter Pharmaceuticals' stock split?

Ritter Pharmaceuticals's stock reverse split on Friday, March 23rd 2018. The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 22nd 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Ritter Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ritter Pharmaceuticals investors own include Endologix (ELGX) , Chipotle Mexican Grill (CMG) , Aegean Marine Petroleum Network (ANW) , Charles Schwab (SCHW) , Genocea Biosciences (GNCA) , Hudson Technologies (HDSN) , Vicor (VICR) , Zoetis (ZTS) and

When did Ritter Pharmaceuticals IPO?

Ritter Pharmaceuticals (RTTR) raised $20 million in an IPO on Wednesday, June 24th 2015. The company issued 4,000,000 shares at $5.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO and Barrington Research was co-manager.

NASDAQ:RTTR

Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free RTTR Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.29
▼
$0.33
50-Day Range: $0.45
▼
$4.09
52-Week Range: $0.15
▼
$1.27

Volume: 27,122 shs
Average Volume: 14.23 million shs
Market Capitalization: $14.39 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Social Media

Get Ritter Pharmaceuticals alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Ritter Pharmaceuticals Stock (NASDAQ:RTTR)

Ritter Pharmaceuticals, Inc. develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance. The company's product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

RTTR Stock News Headlines

January 24, 2024 | health.usnews.com

Dr. John D. Ritter

September 15, 2023 | health.usnews.com

Kristen Ritter

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

July 8, 2023 | health.usnews.com

Dr. Harold K. Ritter

July 1, 2023 | bizjournals.com

Denver Business Journal welcomes new tech reporter

April 10, 2023 | usatoday.com

Jason Ritter and Drew Barrymore's raw conversation on her show may matter more than you think

March 29, 2023 | thestreet.com

Ritter Pharmaceuticals Changing the Game With Lactose Intolerance Treatment

March 18, 2023 | finance.yahoo.com

Global Microbiome Market Report 2023: Major Players Include MicroBiome Therapeutics, Seres Therapeutics, Enterome Bioscience and Second Genome

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

January 19, 2023 | yahoo.com

Melanie Lynskey's husband Jason Ritter will join her in Yellowjackets this season

November 16, 2022 | finance.yahoo.com

Microbiome Clinical Trial Pipeline Space Brims with Novel Emerging Therapies with 130+ Key Players Working in the Domain | DelveInsight

See More Headlines

Receive RTTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ritter Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/01/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:RTTR
CUSIP: N/A
CIK: 1460702
Web: www.ritterpharmaceuticals.com
Phone: 310-203-1000
Fax: N/A
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,130,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -162.05%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.67
Quick Ratio: 3.67

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.10 per share
Price / Book: 3.12

Miscellaneous

Outstanding Shares: 46,153,000
Free Float: N/A
Market Cap: $14.39 million
Optionable: Not Optionable
Beta: -0.43

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Ira Eliot Ritter (Age 70)
Co-Founder, Exec. Chairman & Chief Strategic Officer
Mr. Andrew J. Ritter (Age 36)
Co-Founder, CEO, Pres, Corp. Sec. & Director
Mr. Michael D. Step (Age 59)
Consultant & Director
Mr. John W. Beck CPA (Age 59)
CPA, Chief Financial Officer
Ms. Ellen F. Mochizuki (Age 52)
Consultant

Key Competitors

View All Competitors

RTTR Stock Analysis - Frequently Asked Questions

How were Ritter Pharmaceuticals' earnings last quarter?: Ritter Pharmaceuticals Inc (NASDAQ:RTTR) issued its quarterly earnings results on Friday, May, 1st. The biotechnology company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.01.
When did Ritter Pharmaceuticals' stock split?: Ritter Pharmaceuticals's stock reverse split on Friday, March 23rd 2018. The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 22nd 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
What other stocks do shareholders of Ritter Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ritter Pharmaceuticals investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Charles Schwab (SCHW), Genocea Biosciences (GNCA), Hudson Technologies (HDSN), Vicor (VICR), Zoetis (ZTS) and
When did Ritter Pharmaceuticals IPO?: Ritter Pharmaceuticals (RTTR) raised $20 million in an IPO on Wednesday, June 24th 2015. The company issued 4,000,000 shares at $5.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO and Barrington Research was co-manager.

This page (NASDAQ:RTTR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis

About Ritter Pharmaceuticals Stock (NASDAQ:RTTR)

RTTR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

RTTR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info